We found that metformin was significantly associated with 12 clinical markers of T2D such as insulin clearance, active GLP-1, glucose levels from mixed-meal glucose tolerance test, glucose sensitivity, and blood pressure (Fig. 2a and Supplementary Data 2–4). Here, INS is linked to type 2 diabetes mellitus.